TrialBMC pulmonary medicine2025
Early C-reactive protein reduction predicts survival in COVID-19 severe pneumonia treated with glucocorticoids.
Nicolò Reccardini et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it